Obesity

Weight Loss Improves Predicted 10‐Year Major Adverse Cardiovascular Events (MACE) and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year

Obesity (Silver Spring)Published Randomised controlled trial

Authors' conclusion

Weight loss reduced MACE and T2D risks, but both rebounded with weight regain.

Study context

Population
Sedentary women with overweight (21–49 years); 115 African American115 African American
Participants
221 women
Comparison
Diet+Aerobic vs Diet+Resistance vs Diet-only
Primary endpoint
Changes in predicted 10-year risk for MACE and T2D (cardiometabolic disease staging equations)
Follow-up
Baseline, post-weight loss and 1-year follow-up

Primary result

As reported in the abstract

Baseline to Post-WL to 1 year
MACE risk decreased from Baseline to post-weight loss (Post-WL) and rebounded from Post-WL to 1 year in all groups
all p < 0.001
T2D risk decreased in all groups but rebounded in Diet+Aerobic and Diet-only
all p < 0.001
Diet+Resistance maintained a significant net T2D risk reduction at 1 year
p = 0.003

Further findings

BMI · Baseline, Post-WL, 1 year

Mean BMI decreased from 28.3 to 23.9 kg m-2, with regain to 25.8 at 1 year

Follow-up exercise adherence and T2D risk rebound · 1 year

Follow-up exercise adherence associated with lower T2D risk rebound
P = 0.024

Original publication

Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year. Obesity (Silver Spring). Published 23 August 2026. doi:10.1002/oby.70291

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.